GlassScriptPhysician profile
Michele L Gleason
NPI 1043214588
$1,883.45
in general payments reported to CMS, 2019-2025
22 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.11 · 2020: $109 · 2021: $182 · 2022: $269 · 2023: $531 · 2024: $317 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.99 |
| Education | $117.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $401.89 | 2022-2024 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $288.70 | 2023-2025 | Acthar |
| Bausch & Lomb Americas INC. | $227.81 | 2022-2025 | Xiidra, Vyzulta, Miebo |
| Abbvie INC. | $207.26 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $128.42 | 2020-2022 | |
| Allergan, INC. | $81.65 | 2020-2022 | |
| New World Medical,INC. | $67.52 | 2019 | |
| The Cameron-Ehlen Group, INC. | $66.42 | 2019-2022 | |
| Biotissue Holdings INC. | $65.22 | 2022-2025 | |
| Astellas Pharma US INC | $41.83 | 2024-2025 | Izervay |
| Rayner Intraocular Lenses Limited | $40.74 | 2023 | Omidria, Rayone Aspheric, Rayone Emv |
| Aerie Pharmaceuticals, INC. | $37.61 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $30.67 | 2024-2025 | Tecnis Iol, Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.60 | 2020-2021 | |
| Sight Sciences, INC. | $29.26 | 2023 | Tearcare System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $26.56 | 2025 | Unity |
| Ocular Therapeutix, INC. | $21.60 | 2020 | |
| Topcon Healthcare, INC. | $21.53 | 2025 | |
| Dompe US, INC. | $19.73 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $18.79 | 2023 | |
| Ivantis, INC | $15.19 | 2021 | |
| Glaukos Corporation | $14.45 | 2025 | Idosetr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Gleason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.